Altre lingue

06/11/24 Dimainvest S.r.l. launched voluntary public acquisition offer to acquire Shedir Pharma Group S.p.A. for ?6.6 million.
26/09/24 Shedir Pharma Group S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2024
29/03/24 Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023
28/10/23 Shedir Pharma Group S.p.A.'s Equity Buyback announced on July 11, 2022, has expired.
29/09/23 Shedir Pharma Group S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023
13/04/23 Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2022
29/09/22 Shedir Pharma Group S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2022
11/07/22 Shedir Pharma Group S.p.A. commences an Equity Buyback Plan, under the authorization approved on April 29, 2022.
29/03/22 Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2021
29/09/21 Shedir Pharma Group S.P.A. Reports Earnings Results for the Half Year Ended June 30, 2021
24/07/21 Certain Shares of Shedir Pharma Group S.p.A. are subject to a Lock-Up Agreement Ending on 24-JUL-2021.
25/05/21 Shedir Pharma S p A : GROUP – PRESENTATION (MAY 2021)
29/03/21 Shedir Pharma Group S.P.A. Reports Earnings Results for the Full Year Ended December 31, 2020
02/11/20 Shedir Pharma S p A : PRESENTATION_VIRTUAL AIM CONFERENCE_NEXT GEMs
31/12/19 400,000 Shares of Shedir Pharma Group S.p.A. are subject to a Lock-Up Agreement Ending on 31-DEC-2019.
17/07/19 Shedir Pharma Group S.p.A. has completed an IPO in the amount of €9.9995 million.
Non ci sono risultati per questa ricerca